Michael Penn, MD, PhD

Michael Penn, MD, PhD

Michael L. Penn, Jr., MD, PhD, is the founding partner of Health Equity Ventures—an emerging investment fund seeking to unlock top quartile returns by investing in diverse entrepreneurs and disruptive companies focused on addressing the enormous unmet needs of underserved populations.

Through his advisory firm, Penn Consulting Partners, he leverages deep knowledge of modern neuroscience with mindful awareness and ancient wisdom practices to offer a suite of strategy, innovation, and DEI services for health care organizations, technology companies and startups.

Dr. Penn began his career at Genentech where he led cross-functional teams to support product launches, technology due diligence, creative deal structuring, and the company’s personalized medicine strategy. After Genentech, he was recruited to become a vice president at the Gladstone Institutes. He was later selected to become the CEO of Gladstone Foundation, directing an operation that raised over $10M annually.

He currently sits on the Board of Trustees at St. Francis Memorial Hospital. He holds a BS in biology from HBCU Morehouse College, where he graduated summa cum laude and Phi Beta Kappa. At UCSF, he received his MD and PhD in biomedical sciences.

Achieving optimal health for all

The AMA is confronting inequity at the system and community level to bring health equity to marginalized and minoritized communities in the U.S.